维普中文期刊产品整合服务
84篇 您的检索式:作者名="LADA O"
    题名 作者 年代 出处 被引量
1A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus显示文摘Tiffet O Nicholson AG Ladas G 2003Chest2003,124,1:1
2Coexistence of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers:influence of 'a' determinant variants显示文摘Lada O Benhamou Y Poynard T 0,,:1
3Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of 'a' determinant variants显示文摘Lada O Benhamou Y Poynard T 2006J Virol2006,80,6:1
4Coexistence of hepatitis B surface antigen(HBsAg) and anti-HBs antibodies in chronic hepa- titis B virus carriers: influence of 'α' determinant variants 显示文摘LADA O BENHAMOU Y POYNARD T 2006J Viro12006,80,6:1
5Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients显示文摘Moucari R Mackiewicz V Lada O 2009Hepatology2009,49,22:1
6Early serum HBsAg drop:a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients显示文摘Moucari R Mackiewicz V Lada O 0,,4:1
7Early serum HBsAg drop:A strong predictor of sustained virological response to pe-gylated interferon alfa-2a in HBeAg-negative patients显示文摘Moucari R Mackiewicz V Lada O 0,,04:1
8Treatment of chro-nic hepatitis B显示文摘ASSELAH T LADA O MARCELLIN P 2011Rev Prat2011,61,1:1
9Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers:influence of “a” determinant variants显示文摘Lada O Benhamou Y Poynard T 2006J Virol2006,80,6:1
10Early serum HB- sag drop:a strong predictor of sustained virological re- sponse to pegylated interferon alfa- 2a in HBeAg- nega- tive patients显示文摘Moueari R Mackiewicz V Lada O 2009Hepatology2009,,4:1
11The long-term morbidity of pleu- mperitoneal shunts in the management of recurrent malignant effu- sions 显示文摘Genc O Petrou M Ladas G 2000Eur J Cardiothorac Surg2000,18,2:1
12In Vitro Susceptibility of Lamivudine-resistant Hepatitis B Virus to Adefovir and Tenofovir显示文摘Lada O Benhamou Y Cahour A 2004Antivir Ther2004,9,:1
13Early serum HBsAg drop:a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients 显示文摘Moueari R Mackiewicz V Lada O 2009Hepatology2009,49,4:1
14Coexistence of hepatitis B surface antigen(HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers:influence of 'a' determinant variants显示文摘LADA O BENHAMOU Y POYNARD T 2006J Virol2006,80,:1
15The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions 显示文摘Genc O Petrou M Ladas G 2000Eur J Cardiothorac Surg2000,18,2:1
16The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions显示文摘Genc O Petrou M Ladas G 2000Eur J Cardiothorac Surg2000,18,:1
17In vitro susceptibility of lamivudin resistant hepatitis B virus to adefovir and tenofovir显示文摘Lada O Benhamou Y Cahour A 2004Antivir Ther2004,9,3:1
18In vitro susceptibility of lamivudine-rcsistant hepatitis B virus to adefovir and tenofovir 显示文摘Lada O Benhamou Y Cahour A 2004Antivir Ther2004,9,3:1
19The long-term morbidity of pleuroperi-toneal shunts in the management of recurrent malignant effusions显示文摘Genc O Petrou M Ladas G 2000J Eur Cardiothorac Surg2000,18,2:1
20Coexistence of hepatitis B surface antigen(HBsAg) and anti - HBs antibodies in chronic hepatitis B virus carriers : influence of ' a' determinant variants 显示文摘Lada o Benhamou Y Poynard T 2006J Virol2006,80,6:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费